Clinical and biochemical aspects of lithium therapy.
D000342:Affective Symptoms / Q000188:drug therapy; D001714:Bipolar Disorder / Q000188:drug therapy / Q000517:prevention & control*; D002395:Catecholamines / Q000378:metabolism; D004298:Dopamine / Q000652:urine; D006801:Humans; D008094:Lithium / Q000627:therapeutic use*; D009638:Norepinephrine / Q000652:urine; D012559:Schizophrenia / Q000188:drug therapy; D013997:Time Factors; D014642:Vanilmandelic Acid / Q000652:urine; D014882:Water-Electrolyte Balance / Q000187:drug effects
D002395:Catecholamines; D014642:Vanilmandelic Acid; D008094:Lithium; D004298:Dopamine; D009638:Norepinephrine